INTRODUCTION
Coronary artery bypass graft (CABG) surgery relieves angina symptoms and reduces mortality among ischemic heart disease patients. [1, 2] It remains the gold standard for the treatment of multivessel and left main coronary artery disease.
[3] Since the beginning of 1980s, internal mammary artery (IMA) has been used for CABG.
[4] It is a well-known fact that IMA graft has the greatest long-term patency rates of all the grafts. Its supremacy is due to its high resistance to atherosclerotic damage, [5, 6] its own blood supply through the vasa vasorum, its own innervations, fewer myocytes in tunica media, and a well-constructed Topical vasodilator response in skeletonized internal mammary artery: Is there really a difference?
